The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Does Mounjaro Affect Metabolism?
Mounjaro (tirzepatide) does affect metabolism, though not in the way some people expect. Rather than directly speeding up metabolic rate, Mounjaro works by reducing appetite and helping you feel fuller after smaller meals—which naturally leads to eating less. Through NHS specialist services in the UK, Mounjaro is available on prescription for eligible adults with obesity or overweight with related health conditions. Understanding how this GLP-1 and GIP receptor agonist affects your body can help you make informed decisions about weight management options available through your GP.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro Affects Your Metabolism and Appetite
Mounjaro is a dual GIP and GLP-1 receptor agonist—it activates two separate hormone pathways that naturally regulate appetite and energy use. The medication does not directly increase your metabolic rate (the calories your body burns at rest), but it does influence how much you eat and how your body processes food. Key metabolic effects include:
- Reduced hunger signals: Mounjaro affects brain centres that control appetite, helping suppress food cravings and the desire to eat between meals
- Increased fullness: You may feel satisfied after smaller portions, naturally reducing overall calorie intake
- Slowed gastric emptying: Food moves more slowly from your stomach into the small intestine, extending the sensation of fullness (though this effect often reduces over time)
- Improved blood sugar regulation: The GLP-1 component helps control glucose levels, which can reduce energy crashes and subsequent hunger spikes
NHS data from NICE guidance and clinical trials shows that weight loss with tirzepatide occurs primarily through reduced food intake alongside your own lifestyle changes—diet and physical activity remain essential for success.
Weight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro and Metabolic Rate: What the Evidence Shows
Research indicates that Mounjaro does not significantly increase resting metabolic rate (the number of calories your body burns at rest). Instead, weight loss results from eating less—a calorie deficit created by reduced appetite rather than a faster metabolism. Studies show that any small changes in metabolic rate are offset by the natural metabolic adaptation that occurs during weight loss. What matters most is the combined effect: eating fewer calories through reduced appetite, plus maintaining physical activity and a balanced diet. Your GP or NHS tier 3 specialist can discuss realistic expectations, as individual responses vary. Use our free BMI calculator to assess your current health status, and our GLP-1 weight loss calculator to estimate potential outcomes based on clinical trial data at different doses.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro speed up your metabolism?
No, Mounjaro does not speed up your resting metabolic rate. It reduces appetite and helps you eat less, creating a calorie deficit that leads to weight loss. The medication works on appetite control pathways, not by increasing calorie burn.
How quickly does Mounjaro affect metabolism?
Appetite suppression typically begins within days to weeks of starting Mounjaro, though full effects develop over several weeks as your dose increases. Metabolic adaptation (your body's adjustment to weight loss) occurs gradually over months.
Is Mounjaro available through NHS specialist services in the UK?
Yes, Mounjaro is approved by NICE for NHS use within tier 3 specialist weight management services. You'll need referral from your GP. However, NHS availability varies by region and waiting times can be lengthy in some areas.
How does Mounjaro's metabolic effect compare to other GLP-1 medications like Wegovy?
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) work similarly—reducing appetite rather than speeding metabolism. Mounjaro is a dual GIP/GLP-1 agonist, which may produce slightly greater weight loss in some people, but individual responses vary significantly.
Will my metabolism slow down after stopping Mounjaro?
Metabolic rate does not dramatically drop after stopping Mounjaro, but appetite typically returns to baseline levels. This is why maintaining diet and exercise habits is crucial. Your GP can advise on sustaining weight loss long-term.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.